Common Rheumatoid Arthritis Drug Won't Raise Blood Cancer Risk(Page 3) The study did not present data on any risks associated with new biologic medications, such as Embrel, Humira, and Remicade, which have been available since about 2000, Lindsey and Wilson said. There have been other studies with positive results for one category of these drugs, called TNF-alpha inhibitors, Wilson said. For severe cases, "when we treat them aggressively with a biologic modifier, perhaps we are bringing their risk down to similar to the general population," he said. More information There's more on rheumatoid arthritis at the Arthritis Foundation. Related Links
advertisement
| ||
What's HOTGet our free newsletter
PR Newswire |
 |
The drkoop.com URL and web site are not associated with C. Everett Koop, M.D., former Surgeon General of the United States.
By using this service, you accept our Terms of Use. Please read them. The consumer health information on drkoop.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2004-2008. The HealthCentral Network, Inc. All rights reserved.